City of Bloomington helps residents remove lead paint from their homes
Lead paint can pose a myriad of health risks, including damage to the brain, kidneys, nerves, and blood. According to the CDC, Children under 6 years old and pregnant people are most at risk for lead exposure. Exposure can lead to both physical symptoms and developmental delays.
To combat this health risk, the City of Bloomington is implementing its Lead-Based Paint Hazard Reduction Program. To participate in the program, residents must live in the 61701 zip code and have children under 6 years old living in the home. Eligible properties must also be built before 1978.
Income eligibility is based on household size, which must fall at 80% of the Area Median Income (AMI) per the U.S. Department of Housing and Urban Development. The program will prioritize children with high lead blood levels and pregnant women.
William Besser, the grants manager for the City of Bloomington, explained the program.
'We will have an assessment completed to identify the lead-based paint hazards and then the lead-based paint is either removed or there's some kind of interim control use to eliminate it from becoming a health hazard,' Besser said.
He said the city is taking this health concern seriously.
'Lead-based paint is a real health hazard and the city is diligently using our community development programs for housing rehabilitation to help remove those hazards,' Besser said. 'We are protecting kids and making sure that they have a healthy environment to grow up and learn.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
CDC issues travel alert as chikungunya outbreak surges in China
[Source] The Centers for Disease Control and Prevention (CDC) issued a Level 2 travel alert on Aug. 14 warning of an 'elevated risk' of chikungunya virus exposure in China's Guangdong province. About the virus: The mosquito-borne virus causes high fever, rash and severe joint pain and is transmitted by Aedes aegypti and Aedes albopictus mosquitoes. First identified in 1952 in southern Tanzania, chikungunya is a regular presence in Asia, Africa and the Americas, but this is the first major outbreak recorded in China. Chinese health officials report over 7,000 confirmed cases since June, with the majority in Foshan city. China's outbreak response: Authorities in China have rolled out large-scale control measures similar to those used during the COVID-19 pandemic. Actions include home inspections, mass fumigation by drones and ground teams, isolation of patients under mosquito nets and the release of mosquito-eating fish and larger predatory mosquitoes. Residents who fail to remove standing water face penalties such as fines or temporary power cuts. Reports of unannounced home visits and blood sampling have fueled debate over privacy and the limits of state authority. Spreading beyond borders: The CDC's advisory also applies to Bolivia, Kenya, Sri Lanka and several Indian Ocean territories, urging travelers to 'practice enhanced precautions' to reduce the risk of infection. Globally, chikungunya has been reported in 16 countries and territories in 2025, with more than 240,000 cases and 90 deaths. In Asia, the virus has spread to countries including India, Sri Lanka and Mauritius, while Taiwan confirmed its first imported case from Foshan in early August. Older adults, newborns infected around the time of birth and people with conditions such as diabetes or heart disease face the highest risk of severe illness. Vaccination and prevention efforts: Two chikungunya vaccines, Ixchiq and Vimkunya, are approved for use in the United States and European Union. The CDC recommends vaccination for travelers heading to outbreak zones and stresses preventive measures such as using insect repellent, wearing long sleeves and pants and staying in screened or air-conditioned areas. There is no specific antiviral treatment for chikungunya, and care focuses on relieving symptoms while the body recovers. This story is part of The Rebel Yellow Newsletter — a bold weekly newsletter from the creators of NextShark, reclaiming our stories and celebrating Asian American voices. Subscribe free to join the movement. If you love what we're building, consider becoming a paid member — your support helps us grow our team, investigate impactful stories, and uplift our community. Trending on NextShark: ! Download the NextShark App: Want to keep up to date on Asian American News? Download the NextShark App today!
The Hill
2 hours ago
- The Hill
Credible scientists can't hold up Kennedy's charade for much longer
How much longer can responsible people work for President Trump's Department of Health and Human Services under the leadership of Secretary Robert F. Kennedy Jr.? That question arises every time Kennedy pulls funding for vaccine research or purges respected scientists at the Centers for Disease Control, the U.S. Preventive Services Task Force or the Food and Drug Administration. For a while, it looked like even vaccine critics weren't safe in the Trump administration. During the COVID-19 pandemic, Dr. Vinay Prasad established his reputation as a contrarian, expressing reservations about pediatric vaccination and several common mitigation measures. It was thus no surprise when he was appointed director of the FDA's Center for Biologics Evaluation and Research, which covers vaccine policy. Prasad didn't last three months on the job. He resigned abruptly in late July following attacks by right-wing figures such as Laura Loomer, who labeled him a 'progressive leftist saboteur.' A Health and Human Services statement cited Prasad's desire to spend more time with his family. It has been widely reported, however, that Trump himself forced Prasad's departure, despite the objection of FDA Commissioner Dr. Marty Makary. In another abrupt move, only 10 days later, Prasad abruptly returned to the FDA, evidently at Makary's request but otherwise without explanation. While some of Prasad's views remain quite controversial among many highly regarded physicians and scientists, it is certainly reassuring to see Loomer's malign influence diminished at the FDA. Nonetheless, Kennedy is still in charge of the entire department, and it is likely only a matter of time until he resumes appointing resolute anti-vaxxers, if not widely discredited would-be 'scientists,' to key committees. Makary and Prasad, and other well-credentialed scientists, no doubt believe they can overcome Kennedy's destabilization of medical research, while still contributing to public health. Maybe they are right, and the wisest course is to hold on as long as possible, trying to do good. After all, there is no telling who would replace them. On the other hand, it seems inevitable that Kennedy's pronouncements will increasingly become intolerable. Some CDC employees already worry that the recent deadly attack on their building in Atlanta was motivated by 'RFK Jr's lies about vax safety and CDC scientists.' Meanwhile, Trump has announced that political appointees will soon take over scientific research grant approval, displacing actual scientists, i n order to 'advance the President's policy priorities.' At some point in the degradation of science, there must be a line that ethical administrators will not cross. There is no single answer to whether an official should stay or withdraw from a compromising position, but history does provide cautionary tales. In 1854, a Massachusetts judge named Edward Loring reached a sincere but tragic decision. I described the events in my book, ' Fugitive Justice: Runaways, Rescuers, and Slavery on Trial.' Late that spring, a fugitive from slavery named Anthony Burns, was arrested in Boston and brought before Loring, a federal commissioner under the Fugitive Slave Act of 1850, as well as judge of the Massachusetts Probate Court. Burns's arrest sparked mass protests in Boston, where anti-slavery sentiment was strong. Many Bostonians called upon Loring to resign from the federal commissioner's position. As a probate judge, he administered the estates of widows and orphans, which required compassion, and it was intolerable for him to be involved in the heartless business of slave-hunting. Loring took the criticism to heart, responding with a published statement. 'It is said that the statute is so cruel and wicked that it should not be executed by good men,' he wrote. But that would create a paradox. If humane judges were all to resign, 'then into what hands should its administration fall? Will those who call the statute merciless commit it to a merciless judge?' Although he had deep misgivings about the Fugitive Slave Act, Loring believed he had a duty to preside. Otherwise, judging would 'be confined to those who are reckless of that right in others, or ignorant or careless of the means given for its legal defense, or dishonest in their use.' Those who wish this, Loring continued, 'are more cruel and wicked than the statute, for they would strip from the fugitive the best security and every alleviation the statute leaves them.' Despite his protestations, Loring ruled in favor of the slaveholder, holding that it was required under the law. He sent Burns to Virginia in chains, where he was starved and abused. Burns's supporters, meanwhile, demonstrated the true meaning of humanity by raising funds to obtain his freedom. Burns returned to Boston and later studied theology at Oberlin College, no thanks to Loring. It turned out that a 'good judge,' as Loring believed himself, could not honorably enforce a pitiless law in a racist regime. He was dismissed from the Harvard Law School faculty, and the Massachusetts legislature removed him from the Probate Court. Loring is remembered today, if at all, as an enabler of slavery. Perhaps health officials are currently echoing Loring's lament. 'If I resign, someone very bad will take my place.' But sometimes, complicity is complicity.
Bloomberg
2 hours ago
- Bloomberg
Vaccine Panel Conflicts Hit Record Low Before RFK Jr. Headed HHS
Financial conflicts of interest among experts who help guide US vaccination policy were at record lows in 2024, just before Robert F. Kennedy Jr. took the nation's top health spot and vowed to clean out corruption. In 2024, 5% or fewer of the members on two key panels reported conflicts, defined as financial relationships with companies in areas like research funding, stock ownership or consulting contracts, according to the study published Monday in the Journal of the American Medical Association.
